The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity

被引:130
作者
Nelson, SD [1 ]
Trager, WF [1 ]
机构
[1] Univ Washington, Sch Pharm, Dept Med Chem, Seattle, WA 98195 USA
关键词
D O I
10.1124/dmd.31.12.1481
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Critical elements from studies that have led to our current understanding of the factors that cause the observed primary deuterium isotope effect, (k(H)/k(D)) obs, of most enzymatically mediated reactions to be much smaller than the "true" or intrinsic primary deuterium isotope effect, k(H)/k(D), for the reaction are presented. This new understanding has provided a unique and powerful tool for probing the catalytic and active site properties of enzymes, particularly the cytochromes P450 (P450). Examples are presented that illustrate how the technique has been used to determine k(H)/k(D), and properties such as the catalytic nature of the reactive oxenoid intermediate, prochiral selectivity, the chemical and enzymatic mechanisms of cytochrome P450-catalyzed reactions, and the relative active site size of different P450 isoforms. Examples are also presented of how deuterium isotope effects have been used to probe mechanisms of the formation of reactive metabolites that can cause toxic effects.
引用
收藏
页码:1481 / 1498
页数:18
相关论文
共 118 条
[21]  
COX PJ, 1976, CANCER TREAT REP, V60, P483
[22]   DEUTERIUM-ISOTOPE EFFECTS ON A-RING AND D-RING METABOLISM OF TESTOSTERONE BY CYP2C11 - EVIDENCE FOR DISSOCIATION OF ACTIVATED ENZYME-SUBSTRATE COMPLEXES [J].
DARBYSHIRE, JF ;
GILLETTE, JR ;
NAGATA, K ;
SUGIYAMA, K .
BIOCHEMISTRY, 1994, 33 (10) :2938-2944
[23]   COMPARISON OF LOCATION, SEVERITY, AND DOSE-RESPONSE OF PROXIMAL AXONAL LESIONS INDUCED BY 3,3'-IMINODIIPROPIONITRILE AND DEUTERIUM SUBSTITUTED ANALOGS [J].
DENLINGER, RH ;
ANTHONY, DC ;
AMARNATH, V ;
GRAHAM, DG .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1992, 51 (06) :569-576
[24]   METABOLISM OF CHEMICAL CARCINOGENS [J].
DIPPLE, A ;
MICHEJDA, CJ ;
WEISBURGER, EK .
PHARMACOLOGY & THERAPEUTICS, 1985, 27 (03) :265-296
[25]  
DYBING E, 1989, REV BIOCHEM TOXICOL, V10, P139
[26]  
Ebner T, 1995, MOL PHARMACOL, V48, P1078
[27]  
EISENHAUER EA, 1986, CANCER TREAT REP, V70, P811
[28]   DEUTERIUM-ISOTOPE EFFECTS IN MUTAGENESIS BY NITROSO-COMPOUNDS [J].
ELESPURU, RK .
MUTATION RESEARCH, 1978, 54 (03) :265-270
[29]  
FIALA ES, 1975, CANCER, V36, P2407, DOI 10.1002/1097-0142(197512)36:6<2407::AID-CNCR2820360620>3.0.CO
[30]  
2-W